{"id":"clareon-panoptix-pro","safety":{"commonSideEffects":[{"rate":null,"effect":"Glare or halos around lights"},{"rate":null,"effect":"Reduced contrast sensitivity"},{"rate":null,"effect":"Posterior capsular opacification"}]},"_chembl":{"chemblId":"CHEMBL216386","moleculeType":"Protein","molecularWeight":"1119.29"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This intraocular lens uses advanced diffractive technology to split incoming light into three focal points—distance, intermediate, and near vision—allowing patients to see clearly across a range of distances without glasses. The lens is implanted during cataract surgery to replace the natural lens and restore functional vision at all distances.","oneSentence":"Clareon PanOptix PRO is a trifocal intraocular lens that provides simultaneous vision at multiple focal distances through diffractive optics.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:30:11.663Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cataract surgery with presbyopia correction (distance, intermediate, and near vision)"}]},"trialDetails":[{"nctId":"NCT06401551","phase":"NA","title":"Clareon PanOptix Pro vs. Clareon PanOptix - Study B","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-06-18","conditions":"Aphakia, Presbyopia","enrollment":71},{"nctId":"NCT06400745","phase":"NA","title":"Clareon PanOptix Pro vs. Clareon PanOptix - Study A","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-06-18","conditions":"Aphakia, Presbyopia","enrollment":87},{"nctId":"NCT06555289","phase":"","title":"Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery","status":"RECRUITING","sponsor":"Juliette Eye Institute Research Center","startDate":"2024-10-23","conditions":"Cataract","enrollment":40},{"nctId":"NCT07161635","phase":"NA","title":"Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs","status":"RECRUITING","sponsor":"Alcon Research","startDate":"2025-10-14","conditions":"Aphakia, Presbyopia","enrollment":120},{"nctId":"NCT07076277","phase":"NA","title":"Visual Outcomes in Patients Contralaterally Implanted With PanOptix Pro and Clareon Vivity Compared to Bilateral Implantation of PanOptix Pro","status":"ENROLLING_BY_INVITATION","sponsor":"Brian Shafer","startDate":"2025-08-05","conditions":"Cataract, Multifocal Intraocular Lens","enrollment":346},{"nctId":"NCT06922084","phase":"PHASE4","title":"A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects","status":"RECRUITING","sponsor":"Berkeley Eye Center","startDate":"2025-03-17","conditions":"Cataract","enrollment":320}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Clareon PanOptix PRO","genericName":"Clareon PanOptix PRO","companyName":"Berkeley Eye Center","companyId":"berkeley-eye-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clareon PanOptix PRO is a trifocal intraocular lens that provides simultaneous vision at multiple focal distances through diffractive optics. Used for Cataract surgery with presbyopia correction (distance, intermediate, and near vision).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}